High levels of circulating chemokine (C-X-C motif) ligand 11 are associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis and with chemokine (C-X-C motif) ligand 10

Journal of Interferon and Cytokine Research

Volumn 32, Issue 2, 2012, Pages 74-80

  Antonelli, Alessandro ^a   Ferri, Clodoveo ^b   Ferrari, Silvia Martina ^a   Frascerra, Silvia ^a   Ruffilli, Ilaria ^a   Caponi, Laura ^a   Ulisse, Salvatore ^c   Miccoli, Mario ^a   Miccoli, Paolo ^a   Fallahi, Poupak ^a  

^a UNIVERSITY OF PISA   (Italy)

^b Section of Clinical Pharmacology   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL11 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; THYROID PEROXIDASE ANTIBODY; THYROTROPIN;

ADULT; AGE DISTRIBUTION; ARTICLE; AUTOIMMUNE THYROIDITIS; CONTROLLED STUDY; ECHOGRAPHY; EUTHYROIDISM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; PRIORITY JOURNAL; PROTEIN MOTIF; SEX RATIO; TH1 CELL; THYROID VOLUME; THYROID WEIGHT; TOXIC GOITER;

ADULT; AGE FACTORS; CHEMOKINE CXCL10; CHEMOKINE CXCL11; FEMALE; GOITER, NODULAR; HUMANS; HYPOTHYROIDISM; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; TH1 CELLS; THYROIDITIS, AUTOIMMUNE; THYROTROPIN;

EID: 84856727946     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2011.0051     Document Type: Article

References (30)

1. Albanesi C, Scarponi C, Sebastiani S, Cavani A, Federici M, De Pità O, Puddu P, Girolomoni G. 2000. IL-4 enhances keratinocyte expression of CXCR3 agonistic chemokines. J Immunol 165(3):1395-1402. (Pubitemid 30604571)
2. Antonelli A, Fallahi P, Rotondi M, Ferrari SM, Romagnani P, Grosso M, Ferrannini E, Serio M. 2006a. Increased serum CXCL10 in Graves' disease or autoimmune thyroiditis is not associated with hyper-or hypothyroidism per se, but is specifically sustained by the autoimmune, inflammatory process. Eur J Endocrinol 154(5):651-658. (Pubitemid 43810850)
3. Antonelli A, Fallahi P, Rotondi M, Ferrari SM, Serio M, Miccoli P. 2006b. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy. Br J Surg 93(10):1226-1231. (Pubitemid 44547021)
4. Antonelli A, Ferrari SM, Fallahi P, Frascerra S, Santini E, Franceschini SS, Ferrannini E. 2009. Monokine induced by interferon gamma (IFNgamma) (CXCL9) and IFNgamma inducible T-cell alpha-chemoattractant (CXCL11) involvement in Graves' disease and ophthalmopathy: modulation by peroxisome proliferator-activated receptor-gamma agonists. J Clin Endocrinol Metab 94(5):1803-1809.
5. Antonelli A, Ferrari SM, Fallahi P, Ghiri E, Crescioli C, Romagnani P, Vitti P, Serio M, Ferrannini E. 2010a. Interferonalpha, -beta and -gamma induce CXCL9 and CXCL10 secretion by human thyrocytes: modulation by peroxisome proliferatoractivated receptor-gamma agonists. Cytokine 50(3):260-267.
6. Antonelli A, Ferrari SM, Frascerra S, Di Domenicantonio A, Nicolini A, Ferrari P, Ferrannini E, Fallahi P. 2011a. Increase of circulating CXCL9 and CXCL11 associated with euthyroid or subclinically hypothyroid autoimmune thyroiditis. J Clin Endocrinol Metab 96(6):1859-1863.
7. Antonelli A, Ferrari SM, Frascerra S, Galetta F, Franzoni F, Corrado A, Miccoli M, Benvenga S, Paolicchi A, Ferrannini E, Fallahi P. 2011b. Circulating chemokine (CXC motif ) ligand (CXCL)9 is increased in aggressive chronic autoimmune thyroiditis, in association with CXCL10. Cytokine 55(2):288-293.
8. Antonelli A, Ferrari SM, Frascerra S, Pupilli C, Mancusi C, Metelli MR, Orlando C, Ferrannini E, Fallahi P. 2010b. CXCL9 and CXCL11 chemokines modulation by peroxisome proliferator-activated receptor-alpha agonists secretion in Graves' and normal thyrocytes. J Clin Endocrinol Metab 95(12):E413-E420.
9. Antonelli A, Rotondi M, Fallahi P, Grosso M, Boni G, Ferrari SM, Romagnani P, Serio M, Mariani G, Ferrannini E. 2007. Iodine-131 given for therapeutic purposes modulates differently interferon-gamma-inducible alpha-chemokine CXCL10 serum levels in patients with active Graves' disease or toxic nodular goiter. J Clin Endocrinol Metab 92(4):1485-1490. (Pubitemid 46556429)
10. Antonelli A, Rotondi M, Fallahi P, Romagnani P, Ferrari SM, Buonamano A, Ferrannini E, Serio M. 2004. High levels of circulating CXCL10 are associated with chronic autoimmune thyroiditis and hypothyroidism. J Clin Endocrinol Metab 89(11):5496-5499. (Pubitemid 39518431)
11. Antonelli A, Rotondi M, Fallahi P, Romagnani P, Ferrari SM, Paolicchi A, Ferrannini E, Serio M. 2005. Increase of interferongamma inducible alpha chemokine CXCL10 but not beta chemokine CCL2 serum levels in chronic autoimmune thyroiditis. Eur J Endocrinol 152(2):171-177. (Pubitemid 40309561)
12. Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray PA, Mantovani A, Sinigaglia F. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med 187(1):129-134. (Pubitemid 28044828)
13. Caturegli P, Hejazi M, Suzuki K, Dohan O, Carrasco N, Kohn LD, Rose NR. 2000. Hypothyroidism in transgenic mice expressing IFN-gamma in the thyroid. Proc Natl Acad Sci USA 97(4):1719-1724. (Pubitemid 30118509)
14. Cole KE, Strick CA, Paradis TJ, Ogborne KT, Loetscher M, Gladue RP, Lin W, Boyd JG, Moser B, Wood DE, Sahagan BG, Neote K. 1998. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J Exp Med 187(12):2009-2021. (Pubitemid 28285570)
15. Cox MA, Jenh CH, Gonsiorek W, Fine J, Narula SK, Zavodny PJ, Hipkin RW. 2001. Human interferon-inducible 10-kDa protein and human interferon-inducible T cell alpha chemoattractant are allotopic ligands for human CXCR3: differential binding to receptor states. Mol Pharmacol 59(4):707-715. (Pubitemid 32273999)
16. Dwinell MB, Lü gering N, Eckmann L, Kagnoff MF. 2001. Regulated production of interferon-inducible T-cell chemoattractants by human intestinal epithelial cells. Gastroenterology 120(1):49-59. (Pubitemid 32061868)
17. Erdel M, Laich A, Utermann G, Werner ER, Werner-Felmayer G. 1998. The human gene encoding SCYB9B, a putative novel CXC chemokine, maps to human chromosome 4q21 like the closely related genes for MIG (SCYB9) and INP10 (SCYB10). Cytogenet Cell Genet 81(3-4):271-272. (Pubitemid 28431955)
18. García-López MA, Sancho D, Sánchez-Madrid F, Marazuela M. 2001. Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3 + lymphocytes. J Clin Endocrinol Metab 86(10):5008-5016. (Pubitemid 33020557)
19. Gasperini S, Marchi M, Calzetti F, Laudanna C, Vicentini L, Olsen H, Murphy M, Liao F, Farber J, Cassatella MA. 1999. Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils. J Immunol 162(8):4928-4937. (Pubitemid 29314899)
20. Kimura H, Kimura M, Rose NR, Caturegli P. 2004. Early chemokine expression induced by interferon-gamma in a murine model of Hashimoto's thyroiditis. Exp Mol Pathol 77(3):161-167. (Pubitemid 39422614)
21. Loetscher P, Pellegrino A, Gong JH, Mattioli I, Loetscher M, Bardi G, Baggiolini M, Clark-Lewis I. 2001. The ligands of CXC chemokine receptor 3, I-TAC, Mig, and IP10, are natural antagonists for CCR3. J Biol Chem 276(5):2986-2991.
22. Mach F, Sauty A, Iarossi AS, Sukhova GK, Neote K, Libby P, Luster AD. 1999. Differential expression of three T lymphocyteactivating CXC chemokines by human atheroma-associated cells. J Clin Invest 104(8):1041-1050. (Pubitemid 29536314)
23. Mazanet MM, Neote K, Hughes CC. 2000. Expression of IFNinducible T cell alpha chemoattractant by human endothelial cells is cyclosporin A-resistant and promotes T cell adhesion: implications for cyclosporin A-resistant immune inflammation. J Immunol 164(10):5383-5388. (Pubitemid 30305219)
24. O'Donovan N, Galvin M, Morgan JG. 1999. Physical mapping of the CXC chemokine locus on human chromosome 4. Cytogenet Cell Genet 84(1-2):39-42. (Pubitemid 29218923)
25. Romagnani P, Annunziato F, Lasagni L, Lazzeri E, Beltrame C, Francalanci M, Uguccioni M, Galli G, Cosmi L, Maurenzig L, Baggiolini M, Maggi E, Romagnani S, Serio M. 2001. Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity. J Clin Invest 107(1):53-63. (Pubitemid 32047414)
26. Sauty A, Dziejman M, Taha RA, Iarossi AS, Neote K, Garcia-Zepeda EA, Hamid Q, Luster AD. 1999. The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J Immunol 162(6):3549-3558. (Pubitemid 29313608)
27. Stassi G, De Maria R. 2002. Autoimmune thyroid disease: new models of cell death in autoimmunity. Nat Rev Immunol 2(3):195-204. (Pubitemid 37328766)
28. Tensen CP, Flier J, Rampersad SS, Sampat-Sardjoepersad S, Scheper RJ, Boorsma DM, Willemze R. 1999a. Genomic organization, sequence and transcriptional regulation of the human CXCL 11(1) gene. Biochim Biophys Acta 1446(1-2):167-172. (Pubitemid 29299337)
29. Tensen CP, Flier J, Van Der Raaij-Helmer EM, Sampat-Sardjoepersad S, Van Der Schors RC, Leurs R, Scheper RJ, Boorsma DM, Willemze R. 1999b. Human IP-9: A keratinocytederived high affinity CXC-chemokine ligand for the IP-10/Mig receptor (CXCR3). J Invest Dermatol 112(5):716-722. (Pubitemid 29220713)
30. Wang SH, Bretz JD, Phelps E, Mezosi E, Arscott PL, Utsugi S, Baker JR, Jr. 2002. A unique combination of inflammatory cytokines enhances apoptosis of thyroid follicular cells and transformnondestructive to destructive thyroiditis in experimental autoimmune thyroiditis. J Immunol 168(5):2470-2474. (Pubitemid 34171852)